Europe
-
Insights from gestational diabetes study
A major study of the effects of gestational diabetes, reported today, has traced the impact of different treatments on the success of pregnancies. Read more
-
VR challenge for cancer researchers
Virtual reality tumour maps and other virtual realisations are the aims of researchers awarded major "cancer challenge" awards. Read more
-
Possible benefits from SCID screening
Screening new-born babies for severe combined immunodeficiency could offer advantages from early treatment, according to a new analysis. Read more
-
New warning on e-cigarettes
A senior European cardiologist has called for public health campaigners to be careful of promoting e-cigarettes after new evidence linked them to potential cardiac risk. Read more
-
Socioeconomic risk for mortality
Socioeconomic status must be a major focus of health strategies to reduce mortality, experts say today. Read more
-
High melanoma deaths ‘due to ageing population’
Melanoma death rates will reduce from their current rates by 2050 – but an ageing population will mean that the number of people dying from the disease will continue to be high, a conference has heard. Read more
-
Cancer medicine delays and price rises criticised
Delays in giving people the latest cancer medicines and unjustified price hikes for well-established treatments are disadvantaging patients, European experts have claimed. Read more
-
Analysis backs radiotherapy change for head and neck cancer
Hyperfractionated radiotherapy, combined with chemotherapy, has proved the best treatment for head and neck cancers that have begun to spread, a major European conference will hear today. Read more
-
Glioblastoma cell patterns found
Swedish researchers have reported progress in understanding the cellular origins of different types of glioblastoma tumours. Read more
-
Gene amplification clue to cancer drug resistance
Breast cancer cells develop resistance to aromatase inhibitors by gene amplification, according to the findings of a European research project, unveiled last night. Read more